Learn More
Medchemexpress LLC (2S)-2-[[3-cyclobutyl-5-(3,4,5-trifluorophenoxy)imidazo[4,5-b]pyridin-2-yl]methylamino]propanamide | 1233231-30-5 | 98.3% | 419.4 g/mol | C20H20F3N5O2 | 10MG

Supplier: Medchemexpress LLC HY12507910MG
DSP-2230 (ANP-230) is an orally active small-molecule inhibitor of voltage-gated sodium channels, developed for research into neuropathic pain and sodium-channel pharmacology. It is used in both in vitro and in vivo studies to evaluate inhibition of Nav1.7, Nav1.8, and Nav1.9 and to probe analgesic mechanisms. The compound is supplied as a high-purity research reagent with good solubility in DMSO.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.